Anaplastic Large Cell Lymphoma Clinical Trials in Houston
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Hodgkin Lymphoma
- +2 more
- brentuximab vedotin
- Anaheim, California
- +18 more
2022-04-01
Apr 1, 2022T
Recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Duarte, California
- +3 more
2021-10-04
Oct 4, 2021N
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
- Houston, TexasM D Anderson Cancer Center
2020-10-14
Oct 14, 2020M
Completed
- B-cell Follicular Lymphoma
- +12 more
- Scottsdale, Arizona
- +9 more
2019-02-15
Feb 15, 2019U
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +4 more
- Atlanta, Georgia
- +2 more
2018-07-25
Jul 25, 2018M
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +45 more
- anti-endosialin/TEM1 monoclonal antibody MORAb-004
- +2 more
- Birmingham, Alabama
- +19 more
2016-01-07
Jan 7, 2016N
Terminated
- Anaplastic Large Cell Lymphoma
- Cyclophosphamide
- +4 more
- Houston, TexasM D Anderson Cancer Center
2014-05-29
May 29, 2014N
Completed
- Anaplastic Large Cell Lymphoma
- +2 more
- Houston, TexasM D Anderson Cancer Center
2014-05-21
May 21, 2014N
Completed
- Anaplastic Large Cell Lymphoma
- +5 more
- Chicago, Illinois
- +1 more
2014-05-07
May 7, 2014X
Completed
- Hodgkin Lymphoma
- Anaplastic Large Cell Lymphoma
- XmAb2513
- Chicago, Illinois
- +3 more
2014-04-18
Apr 18, 2014N
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +61 more
- bevacizumab
- cediranib maleate
- Houston, TexasM D Anderson Cancer Center
2014-02-14
Feb 14, 2014